IVI four researchers in the top 10 of the reproductive biology of Spain.
according to the last ranking drawn up from the index h.
-the number of publications and the times that they have been cited to determine the value of index (h)
Valencia, 2011-August four scientific IVI are placed at the head of the research in reproductive biology. Dr. Antonio Pellicer, IVI President, heads the ranking of the best researchers in this category according to the h-index, a study containing the scientific production of greater global impact. Follow Dr. Carlos Simón, scientific director of IVI; Dr. José RemohÃ, President of IVI; and Dr. Juan Antonio Garcia Velasco, director of IVI Madrid.
The study measured simultaneously the quantity and quality of work developed by the researchers, by reference to the publications and the number of times that these have been cited by other professionals from around the world. A higher h value implies a greater influence in the published study. This measurement system, designed by American Jorge e. Hirsch, is used to analyze the information from the prestigious ISI Web of Knowledge database.
In this regard, Dr. Antonio Pellicer takes the lead in the category of reproductive biology with 679 publications and an index h 49. Dr. Carlos Simón occupies the third place with 446 publications and an index (h) 48; Fourthly, is Dr. José Remohà 414 publications and an index (h) 40; and, finally, is the Dr. Juan Antonio Garcia Velasco, with 139 publications and a 24 h-index.
With such prestigious classifications like this and so accepted among the scientific community, it is revealed the quality of the research in Spain and the bet that makes the IVI research group and be at forefront of the latest technologies of assisted reproduction ”, explains Dr. GarcÃa Velasco.
All details of the study are contained here.
On IVI
El Instituto Valenciano de Infertilidad was founded in 1990 as the first medical institution in Spain entirely specialized in human reproduction. Currently there are 20 clinics in eight countries of the world, and is regarded as the leading European institution in reproductive medicine.
